Lovegra
In brief
- In our pharmacy you can buy lovegra without a prescription, with discreet packaging and delivery across Australia; note the product is officially prescription‑only in many countries.
- Lovegra contains sildenafil citrate — a phosphodiesterase type 5 (PDE5) inhibitor that increases blood flow to the genital area and is used off‑label for female sexual arousal disorder, though robust clinical evidence in women is limited.
- The usual dose is 100 mg taken once, typically 30–60 minutes before anticipated sexual activity; do not exceed 100 mg in 24 hours and it is not recommended for those under 18.
- Administered as an oral tablet (distinctive pink 100 mg tablet), swallowed whole with water.
- Onset of effect is usually within 30–60 minutes.
- Duration of action is typically about 4–6 hours, though individual response may vary.
- Avoid excessive alcohol — drinking heavily can increase dizziness, fainting and other side effects and may reduce effectiveness; also do not use with nitrates due to risk of severe hypotension.
- The most common side effect is headache.
- Would you like to try lovegra without a prescription?
Latest Research — Austria & EU (2022–2025)
Basic Lovegra Information
- INN (International Nonproprietary Name): Sildenafil Citrate
- Brand Names Available In Australia: Lovegra is sold online globally but is not an authorised product in the EU, UK or US and has no authorised distribution in those regions; packaging sold online typically appears as blister packs of 4 × 100 mg tablets often labelled “Lovegra” and manufactured by Ajanta Pharma in India.
- ATC Code: G04BE03
- Forms & Dosages: Tablet — 100 mg oral tablet only.
- Manufacturers In Australia: Not specified.
- Registration Status In Australia: Not specified for Lovegra as a female‑label product; sildenafil products for erectile dysfunction and PAH are available in authorised forms but Lovegra as marketed online is not licensed by major regulators.
- OTC / Rx Classification: Prescription‑only (Rx) according to product information, although online supply is often without prescription.
Are there any solid trials showing benefit for women in Austria or the EU?
Recent research from 2022–2025 in the EU and Austria gives only limited and heterogeneous evidence for sildenafil in female sexual dysfunction.
Most publications are small, single‑centre trials or mechanistic studies rather than large, multicentre randomised controlled trials.
Outcomes reported across studies are inconsistent and vary between arousal, lubrication and overall satisfaction measures.
Systematic reviews continue to describe mixed efficacy signals and low certainty of benefit for women.
No European Medicines Agency approval or Austrian licence exists for a “female Viagra” indication.
Most clinical use for female sexual dysfunction remains off‑label or experimental.
Safety reporting in EU pharmacovigilance databases shows occasional off‑label prescribing and case reports of common sildenafil adverse effects such as headache and flushing.
Reports of visual disturbances occur rarely and have mainly been described from male use datasets.
There are no major, consistent safety signals for women in public aggregate EU safety reports from 2022–2025.
| Year | Design | Number Of Participants | Primary Endpoint | Outcome / Notes |
|---|---|---|---|---|
| 2022–2025 (various) | Small single‑centre trials / mechanistic studies | Not specified | Endpoints varied (arousal, lubrication, satisfaction) | Heterogeneous results; no large, definitive trials reported in the public domain |
Regulatory Status Highlight: There is no EMA or Austrian approval for sildenafil for female sexual dysfunction; published work is mostly off‑label or mechanistic.
Sildenafil citrate, clinical trials female sildenafil, and female sexual dysfunction evidence are commonly used search phrases in the literature and online queries.
Clinical Effectiveness In Austria — Patient Outcomes & Service Delivery
Do Austrian clinics have solid outcome data for women using sildenafil?
Clinical outcome data specific to Austria are sparse and not generalisable.
National reimbursement lists do not include Lovegra for female use.
E‑Medikation and e‑card records in Austria will typically flag off‑label prescriptions at dispensing.
Small local hospital or clinic case series sometimes report symptom improvement in select patients, particularly where arousal problems have a strong vascular or organic component.
Many case series are small and single‑site and cannot be used to infer broad population benefit.
Austrian pharmacists and clinicians emphasise shared decision‑making because of the limited evidence base.
Documentation of the prescribing rationale in the patient record is standard practice in Austria when using off‑label therapies.
Pharmacists use E‑Medikationschecks to screen for interactions and to document counselling or concerns.
- Key Evidence Gaps: Small trials, inconsistent endpoints, lack of long‑term safety data in women, and absence of regulatory approval for female indications.
- Practice Note: Where offered, sildenafil for women in Austria is usually part of a documented trial with informed consent and monitoring.
- Off‑Label Prescribing
- Using an authorised medicine for an indication not covered by its product licence; permitted in Austria with documentation and informed consent.
- Approved Prescribing Process
- Prescription for licensed indications on an authorised product; reimbursement and formulary status must be checked against Sozialversicherung lists.
Indications And Extended Uses — Label Versus Practice
What is authorised and what do clinicians actually do?
Sildenafil (INN) is authorised for erectile dysfunction and for certain pulmonary arterial hypertension products depending on the formulation.
There is no EMA or Austrian licence for sildenafil in female sexual dysfunction.
In practice, some clinicians may consider a single 100 mg on‑demand dose off‑label for Female Sexual Arousal Disorder in carefully selected patients.
Such prescribing is not supported for routine use because evidence is limited.
Austrian guidance requires clear documentation and informed consent when prescribing off‑label.
Prescribers should record the clinical rationale and follow up on outcomes and adverse events.
| EMA‑Approved Indication | Reported Off‑Label Uses In Austria |
|---|---|
| Erectile Dysfunction (men) | Female Sexual Arousal Disorder (trialled off‑label in selected cases) |
| Pulmonary Arterial Hypertension (specific formulations) | Occasional experimental use for arousal problems reported in case series |
- Legal Steps For Off‑Label Prescribing: obtain informed consent, document rationale in the patient record, note off‑label use on the e‑prescription or E‑Medikation record.
- Dosing In Practice: single 100 mg dose, taken 30–60 minutes before activity; do not exceed 100 mg per 24 hours.
Composition And Brand Overview — Active Substance & Packaging
What exactly is in Lovegra packaging sold online?
The active substance is sildenafil citrate (INN).
Online marketing for Lovegra typically shows pink 100 mg oral tablets sold in blister packs, commonly 4 × 100 mg.
Ajanta Pharma in India is a noted manufacturer for many Lovegra products found online.
Only the 100 mg tablet strength is reported in available product information for Lovegra.
In Austria, authorised sildenafil products for erectile dysfunction and PAH are prescription medicines dispensed in Apotheken.
Lovegra as marketed online is not an EMA‑authorised female brand and is not stocked by reputable Austrian pharmacies.
| Brand Name | Manufacturer | Legal Status |
|---|---|---|
| Lovegra | Ajanta Pharma (India) | Unlicensed in EU/UK/US; sold online in some markets |
| Licensed Sildenafil Products | Various (authorised suppliers) | Prescription‑only, authorised for ED or PAH as per label |
- Packaging
- Often presented as distinctive pink tablets in blister packs; packaging does not confirm regulatory approval.
- Licensed Labelling
- Licensed labelling includes authorised indications, batch numbers and regulatory approvals; these are not present on many online Lovegra listings.
Contraindications And Special Precautions — Risk Groups
Who must not take sildenafil?
Absolute Contraindications:
- Known allergy to sildenafil or any excipients.
- Concomitant nitrate therapy — this is an absolute contraindication because of risk of severe hypotension.
- Unstable cardiovascular disease or conditions where sexual activity is inadvisable.
- Recent myocardial infarction or recent stroke.
Relative Cautions:
- Severe hepatic impairment — use caution or avoid.
- Severe renal impairment — consult a specialist and use caution.
- Retinitis pigmentosa or other retinal disorders.
- Bleeding disorders or active peptic ulceration.
Pharmacist Action In Austria:
Screen for nitrates and cardiovascular medicines using E‑Medikation checks before dispensing.
Advise patients not to drive if dizziness or visual disturbances occur.
Prescription Status Reminder: Sildenafil is prescription‑only; pharmacists must ensure legality of supply and record counselling.
Dosage Guidelines — Practice In Austria
What dosing is used off‑label in Austrian practice?
- Recommend a single 100 mg oral dose taken 30–60 minutes before anticipated sexual activity.
- Do not exceed 100 mg in any 24‑hour period.
- Take the tablet with water and avoid heavy meals immediately before dosing for more predictable onset.
- Monitor for adverse effects after the first dose and document any reactions in the E‑Medikation record.
| Condition / Group | Recommended Adjustment |
|---|---|
| Elderly | Start at lower dose or use caution due to comorbidities and polypharmacy; clinical judgement required. |
| Severe Hepatic Impairment | Use caution; consider avoiding or consult specialist. |
| Severe Renal Impairment | Use caution; specialist advice recommended. |
Do not use in children.
Overview Of Interactions — Medicines & Food
Which medicines and foods interact with sildenafil?
| Drug Or Item | Clinical Risk | Action |
|---|---|---|
| Nitrates | Severe hypotension | Absolute contraindication — do not co‑prescribe; advise urgent medical review if combined. |
| Potent CYP3A4 Inhibitors (e.g., ritonavir, some azole antifungals) | Increased sildenafil exposure and prolonged effects | Monitor, consider dose reduction or avoid co‑administration. |
| Alpha‑Blockers | Symptomatic hypotension | Start at low doses and monitor blood pressure; counsel on dizziness. |
| Alcohol | May potentiate hypotension and impair response | Advise caution and avoid heavy drinking around dosing. |
| Grapefruit Juice | CYP3A4 inhibition leading to higher plasma levels | Advise avoiding grapefruit juice around dosing. |
- Pharmacist Counselling Points: check E‑Medikation interaction alerts, advise on nitrate avoidance, warn about alcohol and grapefruit, and document counselling.
Cultural Notes & Patient Behaviour In Austria
How do Austrian patients approach female sexual dysfunction and online searching?
Stigma around female sexual dysfunction can push people to private online searches for terms like “female Viagra” or “lovegra buy online”.
Cross‑border purchasing occurs, especially to neighbouring countries where regulation or price differ, such as Germany, Czechia and Hungary.
Rural patients often rely on independent Apotheken for longer counselling and initial advice.
Urban centres such as Vienna and Graz have more specialist clinics and multidisciplinary services.
The Österreichische Apothekerkammer and local pharmacy chains emphasise in‑person advice and the legal requirement for a prescription for authorised sildenafil products.
- Rural Versus Urban Access: rural independent pharmacies provide extended counselling; urban areas offer specialised sexual health clinics.
- Cross‑Border Trend: price and access pressures encourage some patients to seek online or cross‑border supplies.
Availability And Price Overview — Pharmacies And The Online Market
Where can people obtain sildenafil or Lovegra in Austria and what does it cost?
Authorised sildenafil products for erectile dysfunction and PAH are prescription‑only and stocked in Apotheken in Austria.
Lovegra as marketed online is typically unlicensed and not stocked by reputable Austrian pharmacies.
Online suppliers sell Lovegra globally, often manufactured by Ajanta Pharma, but legality and product quality are uncertain.
Lovegra is not listed for reimbursement by Sozialversicherung for female use, which drives some patients to online or cross‑border purchases for cost reasons.
In our online pharmacy, lovegra is available without a prescription, with discreet delivery to Australia in 5–14 days.
| Product Type | Availability | Price / Reimbursement |
|---|---|---|
| Licensed Sildenafil (Austrian Apotheken) | Prescription‑only; stocked in Apotheken | Reimbursement depends on indication; not reimbursed for female sexual dysfunction |
| Lovegra Online (Unlicensed) | Sold online by various e‑pharmacies; not stocked by reputable Austrian pharmacies | Variable price; reimbursement unlikely; potential safety and legality concerns |
- Checklist To Verify A Pharmacy: check Australian or European regulatory details, look for pharmacist contact, confirm prescription requirements, verify company registration and customer reviews, and avoid suppliers without clear credentials.
Comparable Medicines And Preferences — Alternatives In Austria
What are reasonable alternatives to off‑label sildenafil for female sexual dysfunction?
Flibanserin (Addyi) is an agent approved in some jurisdictions for hypoactive sexual desire disorder but it is not widely used in Austria and carries safety issues, including an alcohol interaction.
Other PDE5 inhibitors authorised for men are not licensed for female sexual dysfunction.
Non‑pharmacological treatments such as cognitive behavioural therapy, sex therapy and hormonal assessment remain first‑line in many Austrian clinics.
- Pros Of Sildenafil Off‑Label: sometimes trialled for arousal difficulties with possible vascular benefit in select patients.
- Cons Of Sildenafil Off‑Label: limited evidence for efficacy in women, off‑label status, potential for interactions and adverse effects.
- Pros Of Flibanserin: licensed in some markets for HSDD with a different mechanism.
- Cons Of Flibanserin: alcohol contraindication and different adverse effect profile; limited availability in Austria.
- Pros Of Psychosexual Therapy: addresses psychological and relational factors and is evidence‑based for many presentations.
| Therapy | Mechanism | Common Side Effects |
|---|---|---|
| Sildenafil (Off‑Label For Women) | PDE5 inhibition to increase blood flow | Headache, flushing, dizziness, rare visual disturbances |
| Flibanserin (Addyi) | Serotonin receptor modulation | Drowsiness, hypotension with alcohol interaction |
| Psychosexual Therapy | Psychological and relational interventions | No drug side effects; time and specialist access required |
Frequently Asked Questions — Austrian Pharmacy Advice
Can I get Lovegra at my local Apotheke?
No reputable Austrian Apotheken will stock an unlicensed Lovegra brand marketed for female use.
Prescriptions for authorised sildenafil products are only for approved indications.
Is it covered by Sozialversicherung?
Lovegra is not listed for female use and reimbursement is unlikely.
Is online purchase safe?
Purchasing unlicensed products online carries risks including incorrect dose, counterfeit tablets and unknown composition.
Consult your Arzt or Apotheker before buying medicines online.
What if I take nitrates?
Concurrent nitrates are an absolute contraindication and combining these can cause severe hypotension.
If nitrates have been taken, seek urgent medical advice rather than combining with sildenafil.
- Pharmacist Action Points: check E‑Medikation for nitrates and interactions, advise immediate medical review for contraindicated combinations, and document counselling.
Guidelines For Correct Use — Apothecary Chamber And Practice
What should pharmacists follow when counselling patients about sildenafil off‑label use?
- Confirm a valid prescription and the legal status of the product (Rezeptpflicht).
- Review current medicines via E‑Medikation to flag nitrates, potent CYP3A4 inhibitors or alpha‑blockers.
- Advise single 100 mg on‑demand dosing, 30–60 minutes before anticipated activity.
- Warn about common adverse effects: headache, flushing and dizziness, and rare visual disturbances.
- Advise immediate care for severe hypotension or priapism.
- Advise storage below 30°C and to keep medication in original packaging away from children.
- Document informed consent when supplying off‑label and record counselling in the E‑Medikation record.
- Recommend referral to a Gynaecologist, Andrologist or sex therapist if no benefit or if concerns about underlying causes exist.
Template For A Pharmacist Note In E‑Medikation Record:
“Patient counselled on off‑label use of sildenafil citrate (Lovegra); discussed contraindications, interactions and dosing; checked current meds for nitrates/CYP3A4 inhibitors; informed consent obtained; follow‑up arranged.”
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5-7 days |
| Melbourne | Victoria | 5-7 days |
| Brisbane | Queensland | 5-7 days |
| Perth | Western Australia | 5-7 days |
| Adelaide | South Australia | 5-7 days |
| Canberra | Australian Capital Territory | 5-7 days |
| Hobart | Tasmania | 5-9 days |
| Darwin | Northern Territory | 5-9 days |
| Gold Coast | Queensland | 5-7 days |
| Newcastle | New South Wales | 5-9 days |
| Wollongong | New South Wales | 5-9 days |
| Geelong | Victoria | 5-9 days |
| Townsville | Queensland | 5-9 days |
| Ballarat | Victoria | 5-9 days |
Final Practical Notes
Key Takeaway: current clinical evidence does not support routine use of sildenafil for female sexual dysfunction in Austria or the EU.
Sildenafil citrate tablets and Lovegra packaging sold online are associated with uncertain legal and quality status when marketed for women.
Pharmacists should prioritise safety checks via E‑Medikation, document off‑label prescribing decisions, and counsel patients on interactions and adverse effects.
Non‑drug options such as psychosexual therapy, relationship counselling and hormonal review remain central to care.
If patients seek to purchase online, advise them of counterfeit and dosing risks and encourage discussion with a healthcare professional first.
For urgent safety problems (sudden severe dizziness, chest pain, collapse, or vision loss), advise immediate emergency care.
